|
Re: Article
|
4
|
Resverlogix Corp.
|
Oct 25, 2020 12:45PM
|
|
Re: Why are you invested in RVX
|
4
|
Resverlogix Corp.
|
Jun 18, 2019 03:06PM
|
|
When will the biotech press start buzzing?
|
4
|
Resverlogix Corp.
|
Sep 13, 2018 09:23AM
|
|
Re: Amarin Market Cap
|
4
|
Resverlogix Corp.
|
Jul 08, 2019 12:51PM
|
|
Seeking Alpha news on Resverlogix's lead product candidate for CV disease
|
4
|
Resverlogix Corp.
|
Nov 11, 2015 12:08PM
|
|
American Diabetes Association meeting June 10-14
|
4
|
Resverlogix Corp.
|
May 26, 2016 10:58AM
|
|
Re: ... did some looking back
|
4
|
Resverlogix Corp.
|
Jul 10, 2017 11:29AM
|
|
Re: Trial
|
4
|
Zenith Epigenetics
|
Sep 08, 2016 09:48AM
|
|
Re: BETonMACE top line data
|
4
|
Resverlogix Corp.
|
Jan 18, 2018 08:49AM
|
|
Re: ZEN-3694 & Enzalutamide Combo Trial Now Recruiting
|
4
|
Zenith Epigenetics
|
Dec 07, 2016 12:01AM
|
|
Re: The 3 inflection points: SSRA, Top-Line, Full Data
|
4
|
Resverlogix Corp.
|
Sep 15, 2018 12:05PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
4
|
Resverlogix Corp.
|
Jun 22, 2020 08:32AM
|
|
Re: Evacetrapib fails
|
4
|
Resverlogix Corp.
|
May 18, 2017 08:49AM
|
|
Re: News article on epigenetics
|
4
|
Resverlogix Corp.
|
Apr 02, 2019 09:00AM
|
|
Re: Thoughts....
|
4
|
BIOASIS TECHNOLOGIES INC
|
May 24, 2019 08:25AM
|
|
Re: Targeting Epigenetics as a New Therapy in Vascular Disease and Dementia
|
4
|
Resverlogix Corp.
|
Aug 29, 2019 08:12PM
|
|
Re: Bioasis Announces Positive Results from NHP study w/ xB³-001
|
4
|
BIOASIS TECHNOLOGIES INC
|
Nov 21, 2018 10:29AM
|
|
Re: Conspiracies of sorts
|
4
|
Resverlogix Corp.
|
Sep 28, 2015 12:16PM
|
|
Re: Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
4
|
Resverlogix Corp.
|
Jul 29, 2020 10:22AM
|
|
BIO International June 6-9
|
4
|
Resverlogix Corp.
|
May 26, 2016 11:06AM
|
